Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis - Scorecard - MDSpire

Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis

  • By

  • Niels T. B. Scholte

  • Pascal R. D. Clephas

  • Eric Boersma

  • Muhammed T. Gürgöze

  • Eelko Ronner

  • Lida Feyz

  • Rudolf A. de Boer

  • Robert M. A. van der Boon

  • Jasper J. Brugts

  • February 10, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Effectiveness of Telemonitoring Approaches in Heart Failure: A Meta-Analysis of Patient Outcomes

At a Glance

CategoryDetail
ConditionHeart Failure (HF)
Key MechanismsRemote monitoring (RM) modalities including invasive hemodynamic monitoring and structured telephone support to reduce hospitalisations and mortality
Target PopulationPatients with heart failure across a range of characteristics (age, LVEF, NYHA class, sex)
Care SettingOutpatient management with telemonitoring interventions compared to standard care

Key Highlights

  • Remote monitoring reduces total HF hospitalisations (IRR 0.81), first HF hospitalisations (RR 0.82), and all-cause mortality (RR 0.90).
  • Invasive hemodynamic monitoring ranks highest for reducing total HF hospitalisations.
  • Structured telephone support ranks highest for reducing first HF hospitalisation and all-cause mortality.

Guideline-Based Recommendations

Diagnosis

  • Use clinical and echocardiographic assessment to diagnose heart failure prior to RM implementation.

Management

  • Implement remote monitoring broadly for HF patients to reduce hospitalisations and mortality.
  • Consider invasive hemodynamic monitoring for optimal reduction in total HF hospitalisations.
  • Use structured telephone support to reduce first HF hospitalisation and all-cause mortality.

Monitoring & Follow-up

  • Monitor patient outcomes including HF hospitalisations and mortality to assess RM effectiveness.
  • Regularly evaluate RM modality effectiveness across patient subgroups.

Risks

  • No significant interaction effects found; RM benefits consistent across patient characteristics.
  • Current evidence does not support targeted RM implementation for specific patient subgroups.

Patient & Prescribing Data

31,669 patients with heart failure from 79 randomized trials

Remote monitoring consistently improves outcomes regardless of age, LVEF, NYHA class, sex, or geographic region.

Clinical Best Practices

  • Adopt remote monitoring as a standard adjunct to usual care in heart failure management.
  • Select RM modality based on desired outcome: invasive hemodynamic monitoring for total hospitalisation reduction, structured telephone support for first hospitalisation and mortality reduction.
  • Apply RM broadly without restricting to specific patient subgroups due to lack of differential benefit evidence.

References

Original Source(s)

Related Content